Tonix Pharmaceuticals Announces Exclusive License of Potential Therapeutic or Preventative Fully Human and Murine Anti-SARS-CoV-2 Monoclonal Antibodies : vimarsana.com

13.02.2023 - Immunocompromised Individuals, Including Organ Transplant Recipients, Are at Increased Risk of Severe COVID-19 and Poor Clinical Outcomes SARS-CoV-2 has Mutated to Evade the Formerly EUA-Approved Monoclonal Antibody Therapies and Preventatives ... Seite 1

Related Keywords

Ilya Trakht , Seth Lederman , Tonix Pharmaceuticals , Treatment Guidelines Panel , National Institutes Of Health , Tonix Pharmaceuticals Holding Corp , Drug Administration , Columbia University , Nasdaq , Pharmaceuticals Holding , Chief Executive Officer , Guidelines Panel , Associate Research Scientist , Columbia University Vagelos College ,